Kampanjeplan BioAtla, Inc.
Avansert tidsplan
Enkel graf
Om selskapet BioAtla, Inc.
BioAtla, Inc., биофармацевтическая компания, разрабатывает специфические и селективные терапевтические препараты на основе антител для лечения различных видов рака. Его ведущим кандидатом в продукт является BA3011, условно активный биологический (CAB) конъюгат антитело-лекарственное средство (ADC) для лечения опухолей саркомы мягких тканей и костей, немелкоклеточного рака легкого (NSCLC) и других типов опухолей. flere detaljer| IPO date | 2020-12-16 |
|---|---|
| ISIN | US09077B1044 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | https://www.bioatla.com |
| Цена ао | 0.372 |
| Prisendring per dag: | -3.44% (0.4563) |
|---|---|
| Prisendring per uke: | +36.07% (0.3238) |
| Prisendring per måned: | +17.62% (0.3746) |
| Prisendring over 3 måneder: | -11.81% (0.4996) |
| Prisendring over seks måneder: | -78.92% (2.09) |
| Prisendring per år: | -82.65% (2.54) |
| Prisendring over 3 år: | -80.84% (2.3) |
| Prisendring siden begynnelsen av året: | -31.16% (0.64) |
|
|
Undervurdering
|
Effektivitet
|
|||||||||||||||||||||||||||||||||||||
Utbytte
|
Plikt
|
Vekstimpuls
|
|||||||||||||||||||||||||||||||||||||
| Institusjoner | Volum | Dele, % |
|---|---|---|
| Soleus Capital Management, L.P. | 4065197 | 8.45 |
| Blackrock Inc. | 2884014 | 6 |
| Tang Capital Management, LLC | 2524076 | 5.25 |
| Vanguard Group Inc | 2081370 | 4.33 |
| Morgan Stanley | 1913115 | 3.98 |
| Cormorant Asset Management, LP | 1181115 | 2.46 |
| Deutsche Bank Aktiengesellschaft | 1125203 | 2.34 |
| Renaissance Technologies, LLC | 987500 | 2.05 |
| Geode Capital Management, LLC | 904080 | 1.88 |
| State Street Corporation | 724369 | 1.51 |
| Veileder | Stillingstittel | Betaling | Fødselsår |
|---|---|---|---|
| Mr. Richard A. Waldron | Senior VP & CFO | 617.62k | 1954 (71 år) |
| Ms. Susie Melody | Senior Vice President of Human Resources | N/A | |
| Dr. Cathy Chang Ph.D. | Senior Vice President of Research & Development | N/A | |
| Dr. Jay M. Short Ph.D. | Co-Founder, CEO & Chairman | 1.06M | 1958 (67 år) |
| Dr. Eric L. Sievers M.D. | Chief Medical Officer | 608.18k | 1964 (61 år) |
| Ms. Monica Sullivan | Senior Vice President of Intellectual Property & Contracts | N/A | |
| Dr. Gerhard Frey Ph.D. | Senior Vice President of Technology Development | N/A | |
| Mr. Christian J. Vasquez | Chief Accounting Officer, Controller and Corporate Secretary | 408.75k | 1976 (49 år) |
| Ms. Sheri Lydick | Chief Commercial Officer | N/A | |
| Dr. Bin Zhang M.D., M.Sc. | Senior Vice President of Clinical Development |
Adresse: United States, San Diego, 11085 Torreyana Road - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.bioatla.com
Nettsted: https://www.bioatla.com
